Ethyl n-(methylsulfonyl)glycinate

Catalog No.: 
ACGLYA964
CAS No.: 
88512-39-4
Molecular Formula: 
C5H11NO4S
Molecular Weight: 
181.21
Ethyl n-(methylsulfonyl)glycinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$128.00In stockInquiry
5g96%$401.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl n-(methylsulfonyl)glycinate
IUPAC Nameethyl (methylsulfonyl)glycinate
MDL No.MFCD01212943
Molecular FormulaC5H11NO4S
Molecular Weight181.21
SMILESO=C(OCC)CNS(=O)(C)=O
InChI KeyMGCVGJVQIPYNKV-UHFFFAOYSA-N
Synonym2-methanesulfonamidoacetic acid ethyl ester;ethyl 2-(methylsulfonylamino)ethanoate;ethyl 2-methanesulfonamidoacetate;ethyl N-(methylsulfonyl)glycinate;N-Methylsulfonylglycine ethyl ester;Ethyl (methylsulfonyl)glycinate;Glycine, N-(methylsulfonyl)-, ethyl ester
CAS No.88512-39-4

Synthetic Route by SureRoute

1. ACGLYA964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGLYA964 route product structure diagram
    ACGLYA96488512-39-4In Stock
Inquiry

2. ACGLYA964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDIT374 route compound structure diagram
    ACBDIT374623-33-6In Stock
  2. Plus
  3. ACCSGN568 route compound structure diagram
    ACCSGN5682550-61-0In Stock
  4. Then
  5. ACGLYA964 route product structure diagram
    ACGLYA96488512-39-4In Stock
Inquiry

3. ACGLYA964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACTXZV913 route compound structure diagram
    ACTXZV91335688-18-7In Stock
  4. Then
  5. ACGLYA964 route product structure diagram
    ACGLYA96488512-39-4In Stock
Inquiry

Comments (0)